Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges.
作者信息
Shah Nirali N, Bacher Ulrike, Fry Terry, Calvo Katherine R, Stetler-Stevenson Maryalice, Arthur Diane C, Kurlander Roger, Baird Kristin, Wise Barbara, Giralt Sergio, Bishop Michael, Hardy Nancy M, Wayne Alan S
机构信息
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
出版信息
Am J Hematol. 2012 Sep;87(9):916-22. doi: 10.1002/ajh.23174. Epub 2012 Apr 4.
Abstract
摘要
相似文献
1
Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges.异基因造血干细胞移植后的骨髓增生异常综合征：诊断与治疗挑战
Am J Hematol. 2012 Sep;87(9):916-22. doi: 10.1002/ajh.23174. Epub 2012 Apr 4.
2
Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.晚期尤因肿瘤的异基因和自体干细胞移植。欧洲多中心研究EICESS两个中心长期随访后的最新情况。德国杜塞尔多夫大学医学中心和奥地利维也纳圣安娜儿童医院的干细胞移植项目。
Ann Oncol. 2000 Nov;11(11):1451-62. doi: 10.1023/a:1026539908115.
3
Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality.老年急性髓系白血病或骨髓增生异常综合征患者的异基因造血干细胞移植：误区与现实
Leukemia. 2021 Jan;35(1):225-228. doi: 10.1038/s41375-020-1004-9. Epub 2020 Jul 30.
4
Second allogeneic stem cell transplantation in a patient with hypoplastic myelodysplastic syndrome following a primary diagnosis of aplastic anaemia.再生障碍性贫血初诊后发生低增生性骨髓增生异常综合征患者的第二次异基因干细胞移植
Acta Haematol. 2011;125(3):175-8. doi: 10.1159/000322609. Epub 2010 Dec 30.
5
Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.异基因造血细胞移植治疗高危急性髓系白血病和骨髓增生异常综合征中，移植后环磷酰胺联合抗胸腺细胞球蛋白作为移植物抗宿主病预防。
Acta Haematol. 2021;144(1):66-73. doi: 10.1159/000507536. Epub 2020 May 19.
6
Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation.异基因造血干细胞移植后供者来源骨髓增生异常综合征一家系伴种系 GATA2 突变。
Int J Hematol. 2021 Feb;113(2):290-296. doi: 10.1007/s12185-020-02980-0. Epub 2020 Aug 31.
7
Selection of Patients With Myelodysplastic Syndrome for Allogeneic Hematopoietic Stem Cell Transplantation.骨髓增生异常综合征患者异基因造血干细胞移植的选择
Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S49-52. doi: 10.1016/j.clml.2016.02.023.
8
Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome.骨髓增生异常综合征复发患者行第二次异基因造血干细胞移植的结局。
Br J Haematol. 2019 Jul;186(1):86-90. doi: 10.1111/bjh.15898. Epub 2019 Apr 2.
9
Allogeneic Hematopoietic Cell Transplantation Is Safe and Effective Treatment in Patients with Myelodysplastic Syndromes Seventy Years and Older.异基因造血细胞移植对70岁及以上骨髓增生异常综合征患者是一种安全有效的治疗方法。
Biol Blood Marrow Transplant. 2017 Jan;23(1):1-2. doi: 10.1016/j.bbmt.2016.11.013. Epub 2016 Nov 16.
10
Principles and overview of allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植的原则与概述
Cancer Treat Res. 2009;144:1-21. doi: 10.1007/978-0-387-78580-6_1.
引用本文的文献
1
Current Advances and Challenges in Gene Therapies for Neurologic Disorders: A Review for the Clinician.神经疾病基因治疗的当前进展与挑战：临床医生综述
Neurol Genet. 2025 Jan 13;11(1):e200229. doi: 10.1212/NXG.0000000000200229. eCollection 2025 Feb.
2
Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature.供体细胞源性髓系肿瘤的经验教训：三例报告及文献综述
Life (Basel). 2022 Apr 8;12(4):559. doi: 10.3390/life12040559.
3
Non-Ablative Chemotherapy Followed by HLA-Mismatched Allogeneic CD3 T-Cells Infusion Causes An Augment of T-Cells With Mild CRS: A Multi-Centers Single-Arm Prospective Study on Elderly Acute Myeloid Leukemia and int-2/High Risk Myelodysplastic Syndrome Patients.非清髓性化疗后输注HLA配型不合的异基因CD3 T细胞导致T细胞扩增并伴有轻度细胞因子释放综合征：一项针对老年急性髓系白血病和int-2/高危骨髓增生异常综合征患者的多中心单臂前瞻性研究。
Front Oncol. 2021 Oct 13;11:741341. doi: 10.3389/fonc.2021.741341. eCollection 2021.
4
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case?病例报告：异基因干细胞移植后供体祖细胞导致的骨髓增生异常综合征迟发。我们能从该报告病例中吸取哪些教训？
Front Oncol. 2020 Oct 14;10:564521. doi: 10.3389/fonc.2020.564521. eCollection 2020.
5
A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.人类白细胞抗原不匹配细胞疗法（干细胞微移植）治疗高危骨髓增生异常综合征或转化型急性髓系白血病的研究
Stem Cells Transl Med. 2016 Apr;5(4):524-9. doi: 10.5966/sctm.2015-0196. Epub 2016 Feb 2.
本文引用的文献
1
Hematopoietic growth factors in myelodysplastic syndromes.骨髓增生异常综合征中的造血生长因子。
Semin Oncol. 2011 Oct;38(5):635-47. doi: 10.1053/j.seminoncol.2011.04.014.
2
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas.超高风险儿科肉瘤患儿和年轻成人的低强度异基因造血干细胞移植。
Biol Blood Marrow Transplant. 2012 May;18(5):698-707. doi: 10.1016/j.bbmt.2011.08.020. Epub 2011 Sep 5.
3
Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management.骨髓增生异常综合征：2011 年诊断、风险分层和治疗更新。
Am J Hematol. 2011 Jun;86(6):490-8. doi: 10.1002/ajh.22047.
4
Advances in the prognostication and management of advanced MDS in children.儿童高级 MDS 的预后和管理进展。
Br J Haematol. 2011 Jul;154(2):185-95. doi: 10.1111/j.1365-2141.2011.08724.x. Epub 2011 May 9.
5
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.对于 AML 或 MDS，采用清髓性与非清髓性异基因移植预处理方案的相似结局。
Bone Marrow Transplant. 2012 Feb;47(2):203-11. doi: 10.1038/bmt.2011.69. Epub 2011 Mar 28.
6
Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature.供者细胞源性白血病/骨髓增生异常肿瘤在异基因造血干细胞移植受者中的临床病理研究：10 例病例分析及文献复习
Am J Clin Pathol. 2011 Apr;135(4):525-40. doi: 10.1309/AJCPPJUQ9DNR1GHP.
7
Donor cell-derived leukemia and myelodysplastic neoplasm: unique forms of leukemia.供体细胞衍生的白血病和骨髓增生异常肿瘤：白血病的独特形式。
Am J Clin Pathol. 2011 Apr;135(4):501-4. doi: 10.1309/AJCPXW8DKEG5QMTB.
8
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.SNP array 核型分析在骨髓增生异常综合征及相关髓系恶性肿瘤中的预后影响。
Blood. 2011 Apr 28;117(17):4552-60. doi: 10.1182/blood-2010-07-295857. Epub 2011 Feb 1.
9
NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes.NCCN 临床肿瘤学实践指南：骨髓增生异常综合征。
J Natl Compr Canc Netw. 2011 Jan;9(1):30-56. doi: 10.6004/jnccn.2011.0005.
10
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.美国国立癌症研究所首届异基因造血干细胞移植后复发的生物学、预防和治疗国际研讨会：组织委员会总结和建议。
Biol Blood Marrow Transplant. 2011 Apr;17(4):443-54. doi: 10.1016/j.bbmt.2010.12.713. Epub 2011 Jan 9.
Zotero 插件